Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Maximiliano, Smietniansky"'
Publikováno v:
Revista del Hospital Italiano de Buenos Aires, Vol 41, Iss 4 (2021)
En la medida en que el crecimiento poblacional continúe en aumento, la cantidad de adultos mayores que sufran patología oncológica será cada vez mayor. Esta población, por su heterogeneidad y su comorbilidad diferente de la del adulto joven, req
Externí odkaz:
https://doaj.org/article/46ee71b2a4064824b1cbe3ac419ada24
Autor:
Gisela Zanga, Estefania Drzewiscki, Paula Tagliani, Maximiliano Smietniansky, Maria M. Esnaola y Rojas, Diego Caruso
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background and Aims: In multiple sclerosis (MS), non-adherence/non-persistence is related to suboptimal response to treatment, including disease relapses and the need for more expensive healthcare. The aim of this study was to identify predictors rel
Externí odkaz:
https://doaj.org/article/6e4843943faa4c659e8cbc92b6e07406
Autor:
Maximiliano Smietniansky, Bruno R. Boietti, Mariela A. Cal, María E. Riggi, Giselle P.Fuccile, Luis A. Camera, Gabriel D. Waisman
Publikováno v:
AIMS Medical Science, Vol 3, Iss 1, Pp 52-60 (2015)
Introduction: The world population is aging, and this demographic fact is associated with an increased prevalence of sedentary lifestyles, sarcopenia and frailty; all of them with impact on health status. Biologic reserve determination in the elderly
Externí odkaz:
https://doaj.org/article/136c315da48c43a490134643b89e5c63
Autor:
Diego Caruso, Estefania Drzewiscki, Gisela Zanga, Maria M. Esnaola y Rojas, Maximiliano Smietniansky, Paula Tagliani
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Scientia
Therapeutic Advances in Neurological Disorders
Scientia
Therapeutic Advances in Neurological Disorders
Disease-modifying therapies; Multiple sclerosis; Predictors Terapias modificadoras de la enfermedad; Esclerosis múltiple; Predictores Teràpies modificadores de la malaltia; Esclerosi múltiple; Predictors Background and Aims: In multiple sclerosis
Autor:
Gisela, Zanga, Diego, Caruso, Estefania, Drzewiscki, Maximiliano, Smietniansky, Maria M, Esnaola Y Rojas
Publikováno v:
Medicina. 81(3)
Adherence to prescribed treatment in chronic diseases, as occurs in multiple sclerosis (MS), is a critical factor for a successful therapeutic response. The objective of this study was to evalua te the association between demographic variables and ad
Autor:
Francisco Romeo, Juan Guido Chiabrando, Daniel Berrocal, Carla Agatiello, Mariela Cal, Maximiliano Smietniansky, Ignacio M. Seropian, Cristian Garmendia, Juan Valle Raleigh, Horacio Medina de Chazal
Publikováno v:
Catheterization and Cardiovascular Interventions. 98
BACKGROUND Sarcopenia is a prevalent condition in elderly patients and has been associated with adverse outcomes following transcatheter aortic valve replacement (TAVR). The present study aimed to determine the predictive value of serum creatinine-cy
Autor:
Daniel Berrocal, Carla Agatiello, Francisco Romeo, Mariela Cal, Ignacio M. Seropian, Juan Guido Chiabrando, Maximiliano Smietniansky, Juan Valle Raleigh, Cristian Garmendia
Publikováno v:
Circulation. 142
Introduction: Sarcopenia, a marker of biological senescence, is a robust prognostic indicator of outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS). However, there are no serum markers routinely ava
Autor:
Francisco J, Romeo, Maximiliano, Smietniansky, Mariela, Cal, Cristian, Garmendia, Juan M, Valle Raleigh, Ignacio M, Seropian, Mariano, Falconi, Pablo, Oberti, Vadim, Kotowicz, Carla R, Agatiello, Daniel H, Berrocal
Publikováno v:
Journal of Geriatric Cardiology : JGC
Autor:
Carla Agatiello, Francisco Romeo, Mariela Cal, Juan Valle Raleigh, Vadim Kotowicz, Mariano Falconi, Juan Guido Chiabrando, Daniel Berrocal, Ignacio M. Seropian, Maximiliano Smietniansky
Publikováno v:
Catheterization and Cardiovascular Interventions. 97
BACKGROUND To evaluate the additive prognostic value of myocardial, inflammatory, and renal biomarkers according to frailty status in patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS). METHODS A total of 111 s
Autor:
Maximiliano Smietniansky
Publikováno v:
Evidencia. Actualización en la Práctica Ambulatoria, Vol 14, Iss 2 (2011)
Externí odkaz:
https://doaj.org/article/8631c4b09b3d46dca010fc456827ef6d